EUCTR2012-004764-22-HR进行中（未招募）1 期
Randomised, double-blind, parallel-group, placebo-controlled,fixed-dose study of Lu AE58054 in patientswith mild-moderate Alzheimer’s disease treated withdonepezil; Study 2
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 840
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •The patient has a knowledgeable and reliable caregiver.
- •The patient is an outpatient.
- •The patient has probable AD.
- •The patient has mild to moderate AD.
- •Stable treatment with donepezil.
- •The patient, if a woman, must have had her last natural menstruation =24 months prior to baseline, OR be surgically sterile.
- •The patient, if a man, agrees to protocol-defined use of effective contraception if his female partner is of childbearing potential, OR must have been surgically sterilised prior to the screening visit.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 126
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 714
排除标准
- •The patient has evidence of any clinically significant neurodegenerative disease, or other serious neurological disorders other than AD.
- •The patient has a Diagnostic and Statistical Manual of Mental Disorders, 4th edition, Text Revision (DSM-IV-TR) Axis I disorder other than AD.
- •The patient has evidence of clinically significant disease.
- •The patient's donepezil therapy is likely to be interrupted or discontinued during the study.
- •The patient is currently receiving memantine or has taken memantine within 2 months prior to screening.
研究者
相似试验
进行中（未招募）
不适用
Randomised, double-blind, parallel-group, placebo-controlled, and active referenced study of Lu AA34893 to evaluate the efficacy and safety of three doses Lu AA34893 and quetiapine versus placebo in the treatment of depression in patients with Bipolar I or II DisorderEUCTR2007-002551-17-BEH. Lundbeck a/s600
进行中（未招募）
不适用
Randomised, double-blind, parallel-group, placebo-controlled, and active referenced study of Lu AA34893 to evaluate the efficacy and safety of three doses Lu AA34893 and quetiapine versus placebo in the treatment of depression in patients with Bipolar I or II DisorderEUCTR2007-002551-17-GBH. Lundbeck a/s600
进行中（未招募）
不适用
Randomised, double-blind, parallel-group, placebo-controlled, duloxetine referenced, dose-finding study of Lu AA24530 in Major Depressive DisorderMajor Depressive DisorderEUCTR2007-001071-11-LTH. Lundbeck a/s625
进行中（未招募）
1 期
Randomised, double-blind, parallel-group, placebo-controlled, and active referenced study of Lu AA34893 to evaluate the efficacy and safety of three doses Lu AA34893 and quetiapine versus placebo in the treatment of depression in patients with Bipolar I or II DisorderEUCTR2007-002551-17-DEH. Lundbeck a/s600
进行中（未招募）
不适用
Randomised, double-blind, parallel-group, placebo-controlled, and active referenced study of Lu AA34893 to evaluate the efficacy and safety of three doses Lu AA34893 and quetiapine versus placebo in the treatment of depression in patients with Bipolar I or II DisorderEUCTR2007-002551-17-LTH. Lundbeck a/s600